Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.01 CHF | +0.40% |
|
+9.05% | - |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 34.02x | 4.31x | 1.49x | 5.98x | 18.5x | 26.01x | 0.96% | 49.15B | ||
| -23.69x | 18.62x | -0.69x | 348.44x | -22.41x | -21.68x | -.--% | 40.23B | ||
| 25.19x | 4.77x | 5.22x | 2.79x | 12.06x | 18.37x | -.--% | 34.55B | ||
| 44.97x | 6.67x | 0.28x | 4.49x | 28.67x | 33.94x | -.--% | 33.09B | ||
| 29.73x | 2.19x | 0.88x | 7.68x | 19.76x | 23.58x | 0.42% | 25.19B | ||
| 32.72x | 16.39x | 2.83x | 5.32x | 24.23x | 25.41x | -.--% | 15.92B | ||
| 24.01x | 2.52x | 0.82x | 2.04x | 8.98x | 14.2x | 1.11% | 13.83B | ||
| 24.5x | 1.36x | 0.17x | 1.94x | 11.76x | 13.36x | -.--% | 13.26B | ||
| -22.69x | 337.84x | -0.44x | 14.88x | -22.26x | -21.4x | -.--% | 13.52B | ||
| 60.8x | 5.09x | 0.4x | 9.07x | 25.79x | 28.19x | 0.45% | 11.04B | ||
| -30.17x | 26.71x | -0.72x | 7.19x | 176.62x | -553.87x | -.--% | 10.82B | ||
| -33.5x | 64.23x | 1.59x | 123.47x | -35.15x | -61.34x | -.--% | 11.66B | ||
| -30.79x | 8.91x | -13.52x | 988x | -26.19x | -25.66x | -.--% | 9.96B | ||
| -32.22x | 8.3x | 7.11x | 94.69x | -21.24x | -20.49x | -.--% | 9.34B | ||
| -20.95x | 7.93x | -1.64x | 2439.71x | -17.69x | -16.8x | -.--% | 8.88B | ||
| -144.27x | 4.94x | 1.14x | 5.55x | 29.49x | 165.9x | -.--% | 9.1B | ||
| 18.06x | 2.18x | 1.25x | 4.11x | 10.92x | 14.16x | -.--% | 8.29B | ||
| 33.76x | - | -0.12x | 15.5x | 27.61x | 30.02x | -.--% | 8.46B | ||
| Average | -0.59x | 30.76x | 0.34x | 226.72x | 13.86x | -18.23x | 0.16% | 18.13B | |
| Weighted average by Cap. | 9.14x | 24.15x | 0.80x | 151.14x | 12.25x | -5.72x | 0.24% |
Select your edition
All financial news and data tailored to specific country editions
















